AI
XNPT. XenoPort Reports Favorable Metabolism and Pharmacokinetics of XP23829, a Novel Fumaric Acid Ester, in Phase 1 Trial
Intends to Advance Development for Potential RRMS and/or Psoriasis Treatment
http://finance.yahoo.com/news/xenoport-reports-favorable-metabolism-pharmacokinetics-200000055.html
Intends to Advance Development for Potential RRMS and/or Psoriasis Treatment
http://finance.yahoo.com/news/xenoport-reports-favorable-metabolism-pharmacokinetics-200000055.html
The Penny Ticker.
http://investorshub.advfn.com/The-Penny-Ticker-17412/
5-bagger contest on Dawgg.
http://investorshub.advfn.com/%22Dawgg%22-21519/
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
